Skip to main content
. 2022 Apr 25;29(1):1272–1281. doi: 10.1080/10717544.2022.2027572

Figure 3.

Figure 3.

In vivo inflammation-targeting ability of fucoidan–deoxycholic acid (FD) nanomicelles after intravenous injection via the tail vein. (A) Fluorescence images of the tongue were obtained using an in vivo imaging spectrum system. (B) Semi-quantitative analysis of fluorescence images (n = 3). Data are shown as mean ± SD. (C) Immunofluorescence images of the tongue after administration of DOX/FD nanomicelles (blue, nucleus; green, DOX/FD nanomicelles; purple, blood vessels). DOX: doxorubicin. Scale bar, 50 μm.